retatrutide how often to take A Clinician's Guide Dosing VisualAbstract: Retatrutide reduces body weight

It is known as a triple-agonist , meaning it targets GLP-1, GIP, and glucagon receptors simultaneously

Metabolic Health Benefits Beyond Weight Weight loss numbers capture attention, but metabolic improvements often provide equal or greater health value

A clinician would need to consider why switching is being considered, whether retatrutide is legally accessible, what adverse effects have occurred, and how diabetes medicines or other chronic therapies could be affected

GLP-1 Agonist Medications Targeting GLP-1 has become a primary area of focus for cardiometabolic health, including weight management

How much weight did participants lose in retatrutide clinical trials

The primary endpoint was a change in HbA1c from baseline to 24 weeks, and secondary endpoints included a change in HbA1c and body weight at 36 weeks